What is the Accuray Incorporated stock price forecast?

Accuray Incorporated is currently trading at $0.34. View real-time AI analysis on Alpha Lenz.

What is Accuray Incorporated insider trading activity?

View the latest insider trading data for Accuray Incorporated on Alpha Lenz.

What is Accuray Incorporated's P/E ratio?

Accuray Incorporated's P/E ratio is -21.7.

Accuray Incorporated

NASDAQ · ARAY

$0.34+0.02(+4.81%)Pre-market

Ask about Accuray Incorporated's future dividend policy...

Alpha Chat Insight

“Accuray Incorporated trades at a P/E of -21.7 (undervalued) with modest ROE of -2.5%.”

Ask for details →

Company Overview

Accuray Incorporated is a medical device company specializing in the development and sale of precise tumor treatments. Primarily known for its innovative radiation therapy systems, the company developed technologies such as the CyberKnife System, used for robotic radiosurgery, and the TomoTherapy System, designed for helical radiation therapy. These devices are pivotal in treating a wide range of cancers and are renowned for enhancing precision and accuracy, thereby minimizing damage to surrounding healthy tissues. Accuray's products are extensively used in healthcare facilities worldwide, playing a crucial role in advancing cancer treatment options. By focusing on combining state-of-the-art technology with patient-centered care, Accuray aims to improve therapeutic outcomes and quality of life for cancer patients. Occupying a significant position in the oncology sector, Accuray Incorporated continues to contribute to the evolution of radiation therapy techniques, making cancer care more effective and accessible.

CEOMs. Suzanne Winter M.B.A.

Websitehttps://www.accuray.com

SectorHealthcare

IndustryMedical Devices

Employees990

Company Statistics

FY 2025

Profile

$34.47MMarket Cap

$458.50MRevenue

0.00Shares Out

990Employees

Margins

32.05%Gross

4.38%EBITDA

1.71%Operating

0.25%Pre-Tax

-0.35%Net

Valuation

-21.66P/E

0.42P/B

0.08EV/Sales

7.65EV/EBITDA

-6.09P/FCF

Growth (CAGR)

2.17%Rev 3Yr

3.67%Rev 5Yr

-1.28%Op Inc 3Yr

-8.97%Op Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-0.34%ROA

-2.52%ROE

3.00%ROIC

Financial Health

$57.42MCash & Cash Equivalents

$331.65MNet Debt

479.33%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Accuray Incorporated trades at a P/E of -21.7 (undervalued) with modest ROE of -2.5%.”

Ask for details →

Frequently Asked Questions

Accuray Incorporated (ticker: ARAY) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 990 employees. Market cap is $34M.

The current price is $0.335 with a P/E ratio of -21.66x and P/B of 0.42x.

ROE is -2.52% and operating margin is 1.71%. Annual revenue is $459M.